Becker's Healthcare March 25, 2025
GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth.
The report is based on data collected from scientific literature, pharmacy claims, industry reports, and surveys of pharmacists, providers, health plan executives, large employers, and individual consumers. Claims analysis...